Home/Filings/4/0001214659-21-009542
4//SEC Filing

Oram Jeffrey 4

Accession 0001214659-21-009542

CIK 0001677077other

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 5:00 PM ET

Size

7.0 KB

Accession

0001214659-21-009542

Insider Transaction Report

Form 4
Period: 2021-09-13
Oram Jeffrey
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2021-09-13+2,7782,778 total
  • Exercise/Conversion

    Restricted Stock Grant

    2021-09-132,77897,222 total
    Exp: 2024-09-13Common Stock (2,778 underlying)
Footnotes (3)
  • [F1]Represents the vesting of restricted stock.
  • [F2]Each restricted stock unit is the economic equivalent of one share of Common Stock, par value $0.0001, of Alzamend Neuro, Inc.
  • [F3]The restricted stock grant vests in 36 equal monthly installments commencing on September 13, 2021.

Issuer

Alzamend Neuro, Inc.

CIK 0001677077

Entity typeother

Related Parties

1
  • filerCIK 0001864444

Filing Metadata

Form type
4
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 5:00 PM ET
Size
7.0 KB